- VIVUS, Inc. Announces Intent to Reacquire U.S. and Canadian Rights for Stendra(R) (Avanafil)
- A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
- VIVUS Reports Third Quarter 2015 Financial Results
- VIVUS Announces Qsymia Presentations at Obesity Week 2015
- VIVUS Announces Date of Third Quarter 2015 Update and Financial Results Teleconference
Latest EventsThere are currently no upcoming events
A Growing Pipeline
VIVUS is developing innovative, next-generation therapies to address unmet needs in obesity, diabetes, sleep apnea and sexual health.